Learn more

POPULATION COUNCIL INC

Overview
  • Total Patents
    147
  • GoodIP Patent Rank
    165,438
About

POPULATION COUNCIL INC has a total of 147 patent applications. Its first patent ever was published in 1968. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are ADVANCED VIRAL RES CORP, THERATECH INC and ZONAGEN INC.

Patent filings per year

Chart showing POPULATION COUNCIL INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sitruk-Ware Regine 26
#2 Moo-Young Alfred J 24
#3 Phillips David M 17
#4 Tsong Yun-Yen 15
#5 Maguire Robin A 14
#6 Thorn Mitchell 13
#7 Ghoumari Abdelmouman 10
#8 Bardin C Wayne 10
#9 Saleh Saleh I 10
#10 Rutenberg Naomi 9

Latest patents

Publication Filing date Title
EP3099311A1 Combination product for the prevention of sexually transmitted infections
CA2836388A1 Neuroprotection and myelin repair using st-1435
US2013150810A1 Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
BR112013024084A2 methods for remyelination of a patient, and for treating multiple sclerosis
CN102497855A Multi-layered gradient vaginal ring
US2010256089A1 Unique combinations of antimicrobial compositions
US2007219172A1 Selective testicular 11beta-HSD inhibitors for the treatment of hypergonadism associated disorders and modulation of fertility
CA2615393A1 Methods and compositions for emergency contraception using endothelin receptor antagonists
MX2007000273A Sustained release compositions containing progesterone receptor modulators.
AU2003245252A1 Carrageenan based antimicrobial compositions
BR0210436A Male contraceptive, methods of contraception, and production of a male contraceptive, peptide fragment from the second extracellular domain of a mammalian ocludin, dna molecule, vector, and, non-human host
CA2384474A1 Compositions and methods for protecting against sexually transmitted diseases
EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
CA2469084A1 Androgen as a male contraceptive and non-contraceptive androgen replacement
BR9806213A Transdermal dosage form.
US6767902B2 Androgen as a male contraceptive and non-contraceptive androgen replacement
US6117441A Silicone core long term androgen delivery implant
US5972372A Intravaginal rings with insertable drug-containing core
WO9808471A1 Vaginal application mifepristone
BR9707637A Implantable implant system intended for subcutaneous or local administration and pharmaceutical set